Skip to main content
editorial
. 2022 Sep 5;127(7):1175–1176. doi: 10.1038/s41416-022-01964-7

Fig. 1. AIP as a double agent.

Fig. 1

AIP can behave both as a tumour suppressor, as in somatotroph and lactotroph pituitary neuroendocrine tumours, or as an oncogene as in diffuse large B cell lymphomas or colorectal tumours.